Silence Therapeutics plc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Silence Therapeutics plc (SLNCF) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $60.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-10
- Silence Therapeutics plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$5.60M.
- Silence Therapeutics plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$56.68M, a 176.62% decline year-over-year.
- Silence Therapeutics plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $73.97M.
- Silence Therapeutics plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$110.25M, a 310.07% decline from fiscal 2024.
- Silence Therapeutics plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $52.48M, a 2866.70% increase from fiscal 2023.
- Silence Therapeutics plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $1.77M.
- Silence Therapeutics plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$24.96M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $60.86M 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | -$5.60M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$110.25M 10-K · filed 2026-03-05 | |||
| 2025-09-30 | -$39.62M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$80.02M 10-Q · filed 2026-08-10 | |||
| 2025-03-31 | -$56.68M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $52.48M 10-K · filed 2026-03-05 | |||
| 2024-09-30 | $13.94M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $69.71M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $73.97M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $1.77M 10-K · filed 2025-02-27 | |||
| 2022-12-31 | -$24.96M 10-K · filed 2025-02-27 |